In patients with acute adrenocortical insufficiency prompt recognition and treatment may be life-saving. Treatment should be initiated immediately before confirmation of the diagnosis. As shown by these case reports, junior staff on acute medical and surgical services, to whom these patients usually first present, may not appreciate that (a) hyponatraemia and hyperkalaemia, in the absence of renal failure, should immediately suggest the diagnosis of adrenal insufficiency and (b) treatment should precede confirmation of the diagnosis. Attempts to correct hyperkalaemia due to adrenocortical insufficiency with insulin and infusions of dextrose is inappropriate and potentially dangerous but seems to be a not unusual mistake.
Introduction
Acute adrenocortical insufficiency is an uncommon, potentially fatal condition, that may present to junior staff working on acute general medical or surgical services. General weakness and lethargy are prominent. Gastrointestinal symptoms are also common presenting features with anorexia, nausea and vomiting occurring in the majority of patients, abdominal pain in a third, and diarrhoea in a fifth of cases.
Abdominal pain may be severe enough to be confused with an acute abdomen'. Pigmentation may not be marked and will depend on the severity and duration of the disease.
There are biochemical markers that should raise suspicion of acute adrenal failure. Hyponatraemia, hyperkalaemia and a raised blood urea are typical findings during acute adrenocortical insufficiency. These biochemical abnormalities should beemphasized more than the non-specifIc clinical features. Furthermore, it should be appreciated that hyponatraemia with biochemical features of 'inappropriate antidiuretic hormone secretion' may occur. Hypoglycaemia, usually fasting, may be an alternative or additional presenting feature. It is imperative that adrenocortical insufficiency be considered in patients with such a biochemical picture.
Confirmation of the final diagnosis depends on
demonstrating failure of the serum cortisol to rise to a significant level following stimulation of the adrenal gland with the synthetic corticotrophin tetracosactrin (Synacthen) and, in patients with primary adrenal disease, a raised level of corticotrophin (ACTH). Although in acute adrenal insufficiency, before treatment with hydrocortisone, a random serum cortisol test is not diagnostic because normal or low serum cortisol levels do not exclude the diagnosis which must always beconfirmed by a Synacthen test. However, treatment with hydrocortisone must never be delayed until the results of a random cortisol level or a Synacthen test are available.
Unfortunately, some patients with acute adrenocortical insufficiency still receive inappropriate and potentially dangerous management during initial presentation or crisis. We believe that failure to appreciate the points noted above may be largely responsible for this. Three cases are described.
Case reports
Casel A 36-year-old woman presented to her general practitioner with a 14 week history of tiredness and listlessness and an 8 week history of dizziness, fainting and exhaustion. Sixteen weeks later she became anorexic and nauseated, and developed brown facial pigmentation. Serum T4 was 67 nmolll(referencerange 50-150)and TSH >50 mU11 (reference range 0.5-5.5). She was treated with thyroxine but four days later she developed headache, nausea, abdominal pain and exhaustion and had to discontinue taking the thyroxine. Serum cortisol was <48 nmolll (reference range 250-650). She was admitted to hospital where the diagnoses of autoimmune Addison's disease and hypothyroidism were confirmed. She was treated with hydrocortisone 30 mg, fludrocortisone 50 p.g and thyroxine 50 p,g daily. On this therapy she developed hypokalaemia with a serum potassium of 2.8 mmolll. Fludrocortisone was discontinued and she received potassium chloride 40 mmol daily. She made a clinical recovery and was discharged home on these medications.A fortnight later she was readmitted with a 10-day history of watery diarrhoea, a 3-day history of lethargy, and I-day history of abdominal pain, nausea and vomiting. On examination she did not look particularly ill and there was no postural hypotension. The electrocardiogram showed peakedT-waves in leads II, III, AVF and V2-6. She was given prednisolone 20 mg orally and continued on hydrocortisone 30 mg daily orally. Serum sodium was 132 mmolll (reference range 135-145), potassium 7.3 mmolll (reference range 3.5-5.0) and urea 6.2 mmolll (reference range 2.5-7.5). Because of hyperkalaemia she was also given soluble insulin (6-16 units) and 20-50 ml of50%dextrose solution intravenously, 3, 7 and 18 hours after admission. During this treatment she experienced severe nausea, restlessness and sweating, probably due to unsuspected hypoglycaemia(blood glucose was not measured). Six hours later the serum potassium was 5.1 mmolll. Only then did she receive hydrocortisone 200 mg intravenously and was given fludrocortisone 100p.g orally. This was followed by clinical and biochemical recovery (serum potassium 4.5 mmolll) over the next 18 hours. The Royal Society of Medicine examination revealed tenderness and guarding in the left iliac fossa. Serum sodium was 126 mmolJI, potassium 4.5 mmolJI and urea 14.1 mmolJI. The patient was treated as a case of infective diarrhoea, though stool culture failed to show the presence of bacterial pathogens. Although the diagnosis of Addison's disease was considered no further action was undertaken. Following intravenous fluid replacement he became clinically well and was discharged 3 days after admission. Two weeks later he was readmitted with a recurrence of abdominal pain, nausea, vomiting and dehydration and 12 kg weight loss. Urea and electrolytes were comparable to those during the initial admission and serum amylase was normal. Initially, he received intravenous saline therapy. Two days later the serum sodium was 131 mmolJI, potassium 5.6 mmolll and urea 7.7 mmolJI. A Synacthen test performed 3 days after the second admission revealed undetectable cortisol levels in the basal, 30 min and 60 min serum samples. Only when these results were available was he given hydrocortisone in addition to fluid replacement, whereupon recovery was rapid. Adrenal antibodies were strongly positive and plasma ACTH was 1310 ngll (reference range up to 50) indicating primary adrenocortical failure.
Case 3
A 43-year-old woman, on home parenteral nutrition because of short bowel syndrome, presented with a 10-day history of poor appetite and tiredness and a 4-day history of vomiting. She was mildly dehydrated and had classical Addisonian pigmentation. Blood pressure was 100/80 supine and 80160 erect. Serum sodium 114 mmolJI, potassium 7.2 mmol/l and urea 2.9 mmol/l. A bloodsample was collected for the determination of serum cortisol: She was treated with intravenous saline and received 5 units of soluble insulin and 500 ml of 5% dextrose infusion to correct the hyperkalaemia. This led to clinical and biochemical hypoglycaemia (blood glucose 1.2 mmol/l) with profuse sweating, shaking, palpitation and breathlessness. These symptoms resolved after the intravenous administration of 10% dextrose solution. Approximately 20 hours after admission a short Synacthen test was carried out followed by the administration of hydrocortisone 200 mg intravenously and 30 mg daily orally. Following this she made a rapid clinical and biochemical recovery (serum potassium 4.0 mmol/l), Serum cortisol levels were undetectable before and 30 min after the administration of 250 jl.g of Synacthen. Tests for adrenal antibodies were negative but plasma ACTH was 885 ng/l indicating primary adrenocortical insufficiency.
Discussion
A number ofclinical conditions are potentially fatal but amenable to treatment. Adrenocortical insufficiency falls into this category. Weare concerned that junior hospital doctors on the acute services seem reluctant to administer the appropriate treatment even when the diagnosis is suspected from the typical biochemical features. This is despite the well-recognizedimportance of commencing treatment at that time, long before the final endocrine diagnosis is established':", It is particularly regrettable that junior doctors should have treated the hyperkalaemia rather than considering its cause. We believe that current clinical teaching has failed to emphasize either the characteristic electrolyte disturbance of acute adrenocortical failure or the need to commence treatment before confirming the diagnosis.
It is crucial that appropriate hydrocortisone replacement is not withheld from the acutely ill patient suspected of having Addison's disease (case 2 and 3) until final confirmation is available from the laboratory. Even if ultimately proved unnecessary hydrocortisone will do no harm. Although these patients survived, Addisonian crisis can be fatal. It is also essential to stress that hyperkalaemia in the absence of renal failure and after excluding pseudohyperkalaemia, is due to adrenocortical insufficiency until proved otherwise, and demands immediate saline and hydrocortisone replacement. Therapy with insulin and glucose to reduce hyperkalaemia is not only ineffective in adrenocortical failure (case 1) but hypoglycaemia is likely to occur and intensify the already dangerous situation. Case 1 also illustrates that in patients with hypothyroidism and concomitant adrenal failure thyroxine replacement without hydrocortisone may precipitate an acute adrenocortical crisis.
Our recommendations, aimed at undergraduate and early postgraduate education would be:
(1) Never withhold treatment if adrenal crISIS is suspected. Collect a blood sample for serum cortisol and give parenteral saline and hydrocortisone immediately'[. Confirm the diagnosis after recovery with a Synacthen test", (2) Hyponatraemia with inappropriately high urinary osmolality and sodium excretion is not always due to the 'syndrome of inappropriate antidiuretic hormone secretion'. Consider Addison's disease particularly in the presence of hyperkalaemia, in young people and in the absence of obvious causes. (3) Do not treat hyperkalaemia due to Addison's disease with insulin which may precipitate severe hypoglycaemia. Intravenous saline and hydrocortisone will correct the raised serum potassium level.
